Dawn Perez-Slavinski advises a full range of healthcare industry clients on complex regulatory issues arising in transactional, compliance and operational activities.
With her experience working in the U.S. Department of Health and Human Services, Office of the General Counsel (HHS-OGC), Dawn offers clients unique insight in identifying, assessing and mitigating potential legal challenges. Her practice focuses on several dynamic and highly regulated sectors, including:
- Managed Care – Navigating contracting, reimbursement and operational requirements applicable to health plans, PBMs, delegated entities, and their investors, including restrictions on downstream arrangements, fraud and abuse considerations, network development and participation standards, utilization management and prior authorization practices (including use of AI) and sales and marketing limitations.
- Value-Based Care – Supporting value-based care organizations, healthcare technology vendors providing utilization management and clinical decision‑support tools, and their investors with the formation, development and operation of, and participation in, value‑based care arrangements, including CMS Innovation Center models, the Medicare Shared Savings Program, and commercial risk‑sharing programs.
- Pharmacy Services – Advising specialty pharmacies, 340B program service providers, home infusion companies, and their investors on transactional and operational matters, including regulatory due diligence, licensure and accreditation requirements, reimbursement considerations, and compliance issues impacting integration and ongoing operations.
- Long‑Term & Community‑Based Care – Counseling long‑term care providers, home‑ and community‑based services organizations, and their investors on regulatory, reimbursement and operational requirements, including state licensure and certification, Medicaid waiver and managed long‑term services and supports (MLTSS) participation, staffing and delegation models, care‑transition practices, and federal and state fraud and abuse considerations.
Prior to joining Bass, Berry & Sims, Dawn was a program integrity attorney in the CMS Division of HHS-OGC. In this capacity, she counseled CMS’ Innovation Center on how to create financial protections and flexibilities for various alternative-payment models, including waivers of federal fraud and abuse laws. In addition, Dawn helped CMS evaluate disclosures made under the Self-Referral Disclosure Protocol; review the legality of CMS regulations and guidance; create safeguards to protect the financial integrity of the Medicare and Medicaid programs; and respond to identified program fraud, waste, and abuse. Dawn also provided critical support to the HHS Office of Inspector General and the U.S. Department of Justice, and represented CMS, in False Claims Act investigations and litigation.
In addition, Dawn previously worked in the healthcare and corporate practice groups of a Virginia-based law firm where she focused on provider network contracting and credentialing.
